Cargando…
Immunological features of a lung cancer patient achieving an objective response with anti‐programmed death‐1 blockade therapy
The role of immune checkpoint inhibitors in metastatic lung cancer has been established in recent years and the pretherapeutic profiles of the tumor microenvironment in responders have been increasingly reported. The role of salvage surgery and the immune profiles of the posttherapeutic specimens in...
Autores principales: | Kamata, Toshiko, Yoshida, Shigetoshi, Takami, Mariko, Ihara, Fumie, Yoshizawa, Hiroko, Toyoda, Takahide, Takeshita, Yuichiro, Nobuyama, Seiichi, Kanetsuna, Yukiko, Sato, Tetsuo, Yoshino, Ichiro, Motohashi, Shinichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942425/ https://www.ncbi.nlm.nih.gov/pubmed/31677359 http://dx.doi.org/10.1111/cas.14222 |
Ejemplares similares
-
Blockade of programmed death-1/programmed death ligand pathway enhances the antitumor immunity of human invariant natural killer T cells
por: Kamata, Toshiko, et al.
Publicado: (2016) -
Phase II study of α-galactosylceramide-pulsed antigen-presenting cells in patients with advanced or recurrent non-small cell lung cancer
por: Toyoda, Takahide, et al.
Publicado: (2020) -
Clinical Application of iNKT Cell-mediated Anti-tumor Activity Against Lung Cancer and Head and Neck Cancer
por: Takami, Mariko, et al.
Publicado: (2018) -
Soluble factors derived from neuroblastoma cell lines suppress dendritic cell differentiation and activation
por: Harada, Kazuaki, et al.
Publicado: (2019) -
CD1d expression in glioblastoma is a promising target for NKT cell-based cancer immunotherapy
por: Hara, Ayaka, et al.
Publicado: (2020)